Description
COEMPAKEN Tablets 5/500mg (28’s) offer a comprehensive and effective approach to managing Type 2 Diabetes Mellitus. Each film-coated tablet contains a powerful combination of Empagliflozin 5mg, a Sodium-Glucose Co-Transporter 2 (SGLT2) inhibitor, and Metformin HCl 500mg, a biguanide. Empagliflozin works by helping the kidneys remove excess glucose from the body through urine, thereby lowering blood sugar levels. It also provides significant benefits in reducing the risk of cardiovascular death, hospitalization for heart failure, and the progression of chronic kidney disease in adults with Type 2 Diabetes. Metformin complements this action by decreasing glucose production in the liver and improving the body’s sensitivity to insulin. This synergistic dual action provides robust glycemic control when diet and exercise alone are insufficient. Consistent daily use, as prescribed by a healthcare professional, is essential for optimizing blood sugar levels and realizing the full cardiovascular and renal protective benefits. This is a prescription-only medication.
